Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.95% | 5.67% | 3.27% | 8.72% | 0.17% |
| Total Depreciation and Amortization | -12.00% | -8.75% | -6.30% | -2.38% | 0.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.01% | 13.32% | -3,178.13% | -709.46% | -4,005.88% |
| Change in Net Operating Assets | -586.60% | 29.42% | 161.58% | 145.11% | 112.24% |
| Cash from Operations | -8.84% | 3.10% | 11.38% | 21.51% | 16.23% |
| Capital Expenditure | -3.44% | 5.34% | 18.41% | 24.69% | 33.62% |
| Sale of Property, Plant, and Equipment | -23.53% | -34.48% | -37.80% | 385.00% | 203.57% |
| Cash Acquisitions | -227.62% | 14.43% | 14.43% | 66.95% | 64.63% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.04% | -1,417.78% | -1,957.30% | -1,810.47% | -1,805.71% |
| Cash from Investing | -7.64% | -13.59% | -17.88% | 17.51% | 12.98% |
| Total Debt Issued | -63.32% | -84.08% | -57.08% | 34.65% | 51.17% |
| Total Debt Repaid | 38.21% | 53.26% | -24.24% | -99.77% | -143.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | -33.33% | 25.00% | 25.00% | 25.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.35% | -11.47% | -13.10% | -13.96% | -15.35% |
| Other Financing Activities | -10.34% | 246.43% | 262.90% | 1,366.67% | 222.22% |
| Cash from Financing | -78.00% | -87.52% | -2,411.68% | 16.58% | -26.22% |
| Foreign Exchange rate Adjustments | -162.07% | -10.98% | 21.52% | -394.74% | 59.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.72% | -822.05% | -146.32% | 216.03% | 180.03% |